Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neximmune, Inc. (NEXI) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neximmune, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1538210.
Total stock buying since 2021: $6,056,610.
Total stock sales since 2021: $16,042.
Total stock option exercises since 2021: $521,668.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 1 | $0 | 0 | $0 | 0 | $0 |
| 2023 | 400,000 | $164,000 | 7,825 | $16,042 | 0 | $0 |
| 2022 | 800,600 | $1,782,129 | 0 | $0 | 0 | $0 |
| 2021 | 241,793 | $4,110,481 | 0 | $0 | 127,953 | $521,668 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-06 | 1 | $0 | 0 | $0 | 0 | $0 |
| 2023-11 | 0 | $0 | 7,825 | $16,042 | 0 | $0 |
| 2023-03 | 400,000 | $164,000 | 0 | $0 | 0 | $0 |
| 2022-11 | 200,000 | $96,175 | 0 | $0 | 0 | $0 |
| 2022-06 | 215,696 | $491,000 | 0 | $0 | 0 | $0 |
| 2022-05 | 84,304 | $181,040 | 0 | $0 | 0 | $0 |
| 2022-03 | 300,600 | $1,013,914 | 0 | $0 | 0 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 117,657 | $468,439 |
| 2021-07 | 0 | $0 | 0 | $0 | 3,432 | $17,743 |
| 2021-06 | 0 | $0 | 0 | $0 | 3,432 | $17,743 |
| 2021-03 | 0 | $0 | 0 | $0 | 3,432 | $17,743 |
| 2021-02 | 241,793 | $4,110,481 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-11 | Jones Kristi (President and CEO) | Buy | 1 | .01 | 0 |
| 2023-11-22 | Roemer Alan S. (Director) | Sale | 3,992 | 1.94 | 7,756 |
| 2023-11-21 | Roemer Alan S. (Director) | Sale | 3,833 | 2.16 | 8,286 |
| 2023-03-30 | Barer Sol J (Director) | Buy | 400,000 | .41 | 164,000 |
| 2022-11-17 | Barer Sol J (Director) | Buy | 75,000 | .48 | 35,925 |
| 2022-11-16 | Barer Sol J (Director) | Buy | 125,000 | .48 | 60,250 |
| 2022-06-07 | Verstandig Grant (Director) | Buy | 26,876 | 2.28 | 61,384 |
| 2022-06-06 | Verstandig Grant (Director) | Buy | 25,000 | 2.14 | 53,550 |
| 2022-06-03 | Verstandig Grant (Director) | Buy | 15,000 | 2.23 | 33,375 |
| 2022-06-02 | Verstandig Grant (Director) | Buy | 47,900 | 2.23 | 106,673 |
| 2022-06-02 | Barer Sol J (Director) | Buy | 20,720 | 2.23 | 46,102 |
| 2022-06-01 | Verstandig Grant (Director) | Buy | 40,200 | 2.38 | 95,756 |
| 2022-06-01 | Barer Sol J (Director) | Buy | 40,000 | 2.35 | 94,160 |
| 2022-05-31 | Verstandig Grant (Director) | Buy | 45,024 | 2.11 | 95,135 |
| 2022-05-31 | Barer Sol J (Director) | Buy | 39,280 | 2.19 | 85,905 |
| 2022-03-29 | Jones Kristi (President and CEO) | Buy | 10,000 | 3.74 | 37,400 |
| 2022-03-28 | Verstandig Grant (Director) | Buy | 18,983 | 3.76 | 71,376 |
| 2022-03-25 | Verstandig Grant (Director) | Buy | 131,622 | 4.14 | 544,915 |
| 2022-03-24 | Verstandig Grant (Director) | Buy | 39,995 | 3.35 | 133,983 |
| 2022-03-23 | Barer Sol J (Director) | Buy | 10,000 | 2.67 | 26,650 |
| 2022-03-22 | Barer Sol J (Director) | Buy | 30,000 | 2.41 | 72,300 |
| 2022-03-21 | Barer Sol J (Director) | Buy | 30,000 | 2.14 | 64,080 |
| 2022-03-18 | Barer Sol J (Director) | Buy | 30,000 | 2.11 | 63,210 |
| 2021-12-21 | Roemer Alan S. (Director) | Option Ex | 67,657 | 3.10 | 209,939 |
| 2021-12-21 | Barer Sol J (Director) | Option Ex | 50,000 | 5.17 | 258,500 |
| 2021-07-08 | Trainer John (Chief Financial Officer) | Option Ex | 3,432 | 5.17 | 17,743 |
| 2021-06-08 | Trainer John (Chief Financial Officer) | Option Ex | 3,432 | 5.17 | 17,743 |
| 2021-03-10 | Trainer John (Chief Financial Officer) | Option Ex | 3,432 | 5.17 | 17,743 |
| 2021-02-17 | Jones Kristi (Chief Operating Officer) | Buy | 911 | 17.00 | 15,487 |
| 2021-02-17 | Verstandig Grant (Director) | Buy | 175,000 | 17.00 | 2,975,000 |
| 2021-02-17 | Zeldis Jerome B (Executive VP of Research & Dev) | Buy | 5,882 | 17.00 | 99,994 |
| 2021-02-17 | Barer Sol J (Director) | Buy | 60,000 | 17.00 | 1,020,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NEXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neximmune, Inc. (symbol NEXI, CIK number 1538210) see the Securities and Exchange Commission (SEC) website.